Studies in AD mouse models indicated that PGRN is strongly increased in microglia clustering around amyloid plaques (Pereson et al, 2009) and may also affect amyloid β‐peptide (Aβ) and tau deposition. The gene discussed is MAPT; the disease is Alzheimer disease.